Acadia Healthcare Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Acadia Healthcare Company, Inc. - ACHC

NEW ORLEANS, Aug. 21, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.

PRNewsWire • 8 hours ago

Acadia Healthcare Company: Capacity Expansion Adds To Growth

Acadia Healthcare is rated BUY, driven by a robust capacity expansion pipeline and strong macro demand for mental health services. ACHC's defensible moat stems from its scale—279 facilities, 12.6k beds—positioning it as the largest independent U.S. behavioral healthcare provider. Forward EV/EBITDA of 8.8x reflects a 30% discount to the sector median and 17% below its five-year average, supporting valuation upside.

Seeking Alpha • Aug 19, 2026

Should You Continue to Hold ACHC Stock at an 18.17X P/E Valuation?

ACHC's premium valuation faces a key test as facility growth and stronger EBITDA guidance compete with rising costs and weaker returns.

Zacks Investment Research • Aug 14, 2026

Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

PRNewsWire • Aug 12, 2026

Robbins LLP Notifies Acadia Healthcare (ACHC) Investors that the Lawsuit Survived Defendants' Motion to Dismiss - Contact Robbins LLP for Information

SAN DIEGO, July 31, 2026 /PRNewswire/ -- Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to proceed. The case is continuing after the Court denied defendants' motion to dismiss the amended complaint.

PRNewsWire • Jul 31, 2026

Acadia Healthcare Q2 Earnings Call Highlights

Acadia Healthcare NASDAQ: ACHC reported second-quarter 2026 results that management said were in line with expectations, supported by progress at recently opened facilities, disciplined spending and strong free cash flow generation.

MarketBeat • Jul 29, 2026

Acadia Healthcare Company, Inc. (ACHC) Q2 2026 Earnings Call Transcript

Acadia Healthcare Company, Inc. (ACHC) Q2 2026 Earnings Call Transcript

Seeking Alpha • Jul 30, 2026

Acadia Healthcare Q2 Earnings Beat Estimates on Higher Admissions

ACHC beats Q2 earnings and revenue estimates as admissions rise and residential treatment grow, prompting higher 2026 guidance despite profit pressure.

Zacks Investment Research • Jul 29, 2026

Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Results Revenue totaled $865.8 million, which was approximately flat compared with the second quarter of 2025. As described on page 2, total revenue growth in the second quarter was 2.8%1 after normalizing for prior period supplemental payment program revenue in each of the respective quarte.

Business Wire • Jul 28, 2026

Acadia Healthcare Stockholders: Contact Robbins LLP for Information About The Class Action Lawsuit Against ACHC

SAN DIEGO, July 28, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to proceed. The case is continuing after the Court denied defendants' motion to dismiss the amended complaint.

GlobeNewsWire • Jul 28, 2026